Standard Risk B-precursor Acute Lymphoblastic Leukemia: A Phase III Groupwide Study

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://clinicaltrials.gov/show/NCT00103285

2. Intervention

   Cyclophosphamide

3. Intervention

   Cytarabine

4. Intervention

   Dexamethasone

5. Intervention

   Doxorubicin hydrochloride

6. Intervention

   Leucovorin calcium

7. Intervention

   Mercaptopurine

8. Intervention

   Methotrexate

9. Intervention

   Pegaspargase

10. Intervention

    Thioguanine

11. Intervention

    Vincristine sulfate

12. Intervention

    Radiation therapy

13. Additional Name

    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

14. Contact

    Berenberg, Jeffrey

15. PI

    Wilkinson, Robert, M.D.

16. Topic

    precursor B lymphoblastic lymphoma/leukemia

17. Study Population

    Children between 1 and 10 years, with initial white count < 50,000, previously enrolled on COG study # AALL03B1, who are newly diagnosed with B-precursor ALL and have had no prior cytotoxic therapy.

18. Funded by

    Children's Oncology Group

19. Phase

    Phase 3 clinical trial

20. Performed by

    Clinical Protocol & Data Management Shared Resource